ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

At Seattle Children’s, Another Piece of Ambitious CAR-T Plan in Place – Xconomy

Continue reading

2017-11-17 Michael Zand NEWS

At Seattle Children’s, Another Piece of Ambitious CAR-T Plan in Place – Xconomy


Xconomy

At Seattle Children’s, Another Piece of Ambitious CAR–T Plan in Place
Xconomy
The researchers and doctors at Seattle Children’s are embarking upon a complicated quest, involving multiple clinical studies of cutting-edge CAR–T cell therapies, to help kids and young adults with an aggressive form of leukemia. As of today, one key …
Inside Seattle Children’s landmark $1B campaign to cure childhood cancer and other diseasesGeekWire

all 3 news articles »

Continue reading

2017-11-17 Michael Zand NEWS

Global Synthetic Biology Market Forecast to 2023 – Developments in Production of Bio-Based Chemicals and Fuels … – Business Wire (press release)

Global Synthetic Biology Market Forecast to 2023 – Developments in Production of Bio-Based Chemicals and Fuels …Business Wire (press release)The market report provides analysis of synthetic biology applications in environmental, medical and industria… Continue reading

2017-11-17 Michael Zand NEWS

Paraplegic rats walk after receiving stem cell therapy in a breakthrough scientists say ‘gives hope’ paralysed … – Daily Mail


Xconomy

At Seattle Children’s, Another Piece of Ambitious CAR–T Plan in Place
Xconomy
The researchers and doctors at Seattle Children’s are embarking upon a complicated quest, involving multiple clinical studies of cutting-edge CAR–T cell therapies, to help kids and young adults with an aggressive form of leukemia. As of today, one key …

Continue reading

2017-11-17 Michael Zand NEWS

Revolutionary New Stem Cell Clinical Trials Geared Towards Autism and Cerebral Palsy – PR Newswire (press release)

Revolutionary New Stem Cell Clinical Trials Geared Towards Autism and Cerebral PalsyPR Newswire (press release)"I am very excited to see the advancement in clinical trials of cord blood and stem cell research that will benefit those with Autism an… Continue reading

2017-11-17 Michael Zand NEWS

Unlike CRISPR Knockout and RNAi Knockdown, Trim-Away Depletes Proteins Straightaway – Genetic Engineering & Biotechnology News

Unlike CRISPR Knockout and RNAi Knockdown, Trim-Away Depletes Proteins StraightawayGenetic Engineering & Biotechnology NewsIf the cell is deprived of the protein indirectly, at the level of protein-coding DNA or RNA (that is, via CRISPR/Cas9 knockout o… Continue reading

2017-11-17 Michael Zand NEWS

Unlike CRISPR Knockout and RNAi Knockdown, Trim-Away Depletes Proteins Straightaway – Genetic Engineering & Biotechnology News

Unlike CRISPR Knockout and RNAi Knockdown, Trim-Away Depletes Proteins StraightawayGenetic Engineering & Biotechnology NewsIf the cell is deprived of the protein indirectly, at the level of protein-coding DNA or RNA (that is, via CRISPR/Cas9 knockout o… Continue reading

2017-11-17 Michael Zand NEWS

Swiss lab develops genetic tool kit to turn any cell into a tumor killer – Ars Technica


Daily Mail

Paraplegic rats walk after receiving stem cell therapy in a breakthrough scientists say ‘gives hope’ paralysed …
Daily Mail
After just three weeks, 42 per cent of the rodents improved their ability to walk and support their weight, a study found. Some 75 per cent of the animals were able to respond to stimuli on their back legs after being treated, the research adds. Stem …

and more »

Continue reading

2017-11-17 Michael Zand NEWS
  • 1
  • …
  • 873
  • 874
  • 875
  • 876
  • 877
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Ars Technica

Swiss lab develops genetic tool kit to turn any cell into a tumor killer
Ars Technica
We’ve made some impressive advances toward inducing the immune system to attack cancers. One of these techniques, using CAR–T cells, is amazing. CAR–T cells are made by inserting receptors that recognize cancerous cells into a leukemia patient’s own …

and more »